Authors
Loading...
Preclinical study demonstrates synergistic antitumor activity via exosome-micelle codelivery of decitabine and sorafenib in neuroblastoma models, highlighting a dual epigenetic-ferroptotic strategy.
Xing et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: